help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2004-0942
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Figueiredo, B. C.
Right arrow Articles by Haddad, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Figueiredo, B. C.
Right arrow Articles by Haddad, B. R.
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Pediatric Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 2 615-619
Copyright © 2005 by The Endocrine Society

Amplification of the Steroidogenic Factor 1 Gene in Childhood Adrenocortical Tumors

Bonald C. Figueiredo, Luciane R. Cavalli, Mara Albonei D. Pianovski, Enzo Lalli, Romolo Sandrini, Raul C. Ribeiro, Gerard Zambetti, Luiz DeLacerda, Giovanna Assis Rodrigues and Bassem R. Haddad

Department of Pediatrics, Center for Molecular Genetics and Cancer Research in Children (CEGEMPAC) (B.C.F., M.A.D.P., G.A.R.), Department of Pediatrics, Division of Pediatric Hematology and Oncology (M.A.D.P.), and Department of Pediatrics, Division of Pediatric Endocrinology (R.S., L.D.), Federal University of Paraná, Curitiba PR 80.030-110, Brazil; Department of Oncology and Institute for Molecular and Human Genetics/Lombardi Comprehensive Cancer Center (L.R.C., B.R.H.), Georgetown University, Washington, DC 20007; Institut de Génétique et de Biologie Moléculaire et Cellulaire Centre National de Ciencia y Tecnologia–Institut National de la Santé et de la Recherche Médicale (E.L.), Université Louis Pasteur, 67404 Illkirch, France; Departments of Hematology-Oncology (R.C.R.) and Biochemistry (G.Z.) and the International Outreach Program (R.C.R.), St. Jude Children’s Research Hospital, Memphis, Tennessee 38105; and Department of Pediatrics (R.C.R.), University of Tennessee, College of Medicine, Memphis, Tennessee 38163

Address all correspondence and requests for reprints to: Bassem R. Haddad, M.D., Institute for Molecular and Human Genetics, Georgetown University Medical Center, 3800 Reservoir Road NW, Main 4000, Washington, DC 20007. E-mail: haddadb1{at}georgetown.edu.

Southern Brazil has one of the highest incidences of childhood adrenocortical tumors (ACTs), occurring 10–15 times more frequently than worldwide estimates. The reasons for this increase remain elusive. In an attempt to further characterize the genetic changes in childhood ACTs, we recently detected a consistent gain of 9q (or a portion of it) in eight of nine cases of pediatric ACTs and amplification of 9q34 in the majority of these cases using comparative genomic hybridization. Other studies involving both childhood and adult ACTs have corroborated these findings. To follow up on these results, we examined whether the steroidogenic factor 1 (SF-1) gene, which is located in this chromosomal region and plays an important role in the development and function of the adrenal cortex is amplified in these ACT cases. We detected increased copy number of the SF-1 gene in all eight cases with 9q gain, suggesting an association between an increased copy number of the SF-1 gene and adrenocortical tumorigenesis.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. Doghman, J. Cazareth, D. Douguet, F. Madoux, P. Hodder, and E. Lalli
Inhibition of Adrenocortical Carcinoma Cell Proliferation by Steroidogenic Factor-1 Inverse Agonists
J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2178 - 2183.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. C. Kim, F. M. Barlaskar, J. H. Heaton, T. Else, V. R. Kelly, K. T. Krill, J. O. Scheys, D. P. Simon, A. Trovato, W.-H. Yang, et al.
In Search of Adrenocortical Stem and Progenitor Cells
Endocr. Rev., May 1, 2009; 30(3): 241 - 263.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
M. Bielinska, H. Parviainen, S. Kiiveri, M. Heikinheimo, and D. B. Wilson
REVIEW PAPER: Origin and Molecular Pathology of Adrenocortical Neoplasms
Vet. Pathol., March 1, 2009; 46(2): 194 - 210.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
A. C. Kim, A. L. Reuter, M. Zubair, T. Else, K. Serecky, N. C. Bingham, G. G. Lavery, K. L. Parker, and G. D. Hammer
Targeted disruption of {beta}-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex
Development, August 1, 2008; 135(15): 2593 - 2602.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
P. S. H. Soon, K. L. McDonald, B. G. Robinson, and S. B. Sidhu
Molecular Markers and the Pathogenesis of Adrenocortical Cancer
Oncologist, May 1, 2008; 13(5): 548 - 561.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
R Natrajan, W Warren, B Messahel, J S Reis-Filho, M-A Brundler, J S Dome, P E Grundy, G Vujanic, K Pritchard-Jones, and C Jones
Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours
J. Clin. Pathol., January 1, 2008; 61(1): 95 - 102.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Doghman, T. Karpova, G. A. Rodrigues, M. Arhatte, J. De Moura, L. R. Cavalli, V. Virolle, P. Barbry, G. P. Zambetti, B. C. Figueiredo, et al.
Increased Steroidogenic Factor-1 Dosage Triggers Adrenocortical Cell Proliferation and Cancer
Mol. Endocrinol., December 1, 2007; 21(12): 2968 - 2987.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Doghman, M. Arhatte, H. Thibout, G. Rodrigues, J. De Moura, S. Grosso, A. N. West, M. Laurent, J.-C. Mas, A. Bongain, et al.
Nephroblastoma Overexpressed/Cysteine-Rich Protein 61/Connective Tissue Growth Factor/Nephroblastoma Overexpressed Gene-3 (NOV/CCN3), a Selective Adrenocortical Cell Proapoptotic Factor, Is Down-Regulated in Childhood Adrenocortical Tumors
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3253 - 3260.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. N. West, G. A. Neale, S. Pounds, B. C. Figueredo, C. Rodriguez Galindo, M. A. D. Pianovski, A. G. Oliveira Filho, D. Malkin, E. Lalli, R. Ribeiro, et al.
Gene Expression Profiling of Childhood Adrenocortical Tumors
Cancer Res., January 15, 2007; 67(2): 600 - 608.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. H. Bassett, B. Mayhew, K. Rehman, P. C. White, F. Mantero, G. Arnaldi, P. M. Stewart, I. Bujalska, and W. E. Rainey
Expression Profiles for Steroidogenic Enzymes in Adrenocortical Disease
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5446 - 5455.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society